Literature DB >> 9351000

Sequential assignments and secondary structure of the RNA-binding transcriptional regulator NusB.

A S Altieri1, M J Mazzulla, H Zhou, N Costantino, D L Court, R A Byrd.   

Abstract

The NusB protein is involved in transcriptional regulation in bacteriophage lambda. NusB binds to the RNA form of the nut site and along with N, NusA, NusE and NusG, stabilizes the RNA polymerase transcription complex and allows stable, persistent antitermination. NusB contains a 10 residue Arg-rich RNA-binding motif (ARM) at the N-terminus but is not sequentially homologous to any other proteins. In contrast to other known ARM-containing proteins, NusB forms a stable structure in solution in the absence of RNA. NMR spectroscopy was used to determine that NusB contains six alpha-helices: R10-Q21, 127-F34, V45-L65, Q79-S93, Y100-F114 and D118-L127. The structure of NusB makes it a member of a newly emerging class of alpha-helical RNA-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351000     DOI: 10.1016/s0014-5793(97)01128-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  In vivo effect of NusB and NusG on rRNA transcription antitermination.

Authors:  Martha Torres; Joan-Miquel Balada; Malcolm Zellars; Craig Squires; Catherine L Squires
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

2.  Solution structure of the antitermination protein NusB of Escherichia coli: a novel all-helical fold for an RNA-binding protein.

Authors:  M Huenges; C Rölz; R Gschwind; R Peteranderl; F Berglechner; G Richter; A Bacher; H Kessler; G Gemmecker
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

3.  Structural basis for RNA recognition by NusB and NusE in the initiation of transcription antitermination.

Authors:  Jason R Stagno; Amanda S Altieri; Mikhail Bubunenko; Sergey G Tarasov; Jess Li; Donald L Court; R Andrew Byrd; Xinhua Ji
Journal:  Nucleic Acids Res       Date:  2011-06-07       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.